Valeo Pharma Inc. Stock Canadian Securities Exchange
Stocks
VPH
CA91915B1085
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6600 CAD | -.--% |
|
+1.54% | -10.81% |
| Market Cap | 6.24M 4.45M 3.89M 3.59M 3.31M 429M 6.38M 42.92M 16.88M 210M 16.72M 16.35M 723M | P/E 2022 |
-2.09x | P/E 2023 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 64.5M 46.04M 40.23M 37.12M 34.22M 4.43B 65.93M 444M 175M 2.17B 173M 169M 7.47B | EV / Sales 2022 |
3.37x | EV / Sales 2023 | 1.35x |
| Free-Float |
52.66% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Tougas
DFI | Director of Finance/CFO | - | 2023-11-19 |
Nelly Komari
CTO | Chief Tech/Sci/R&D Officer | - | 2021-05-31 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 2019-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CHM | Chairman | 67 | 2024-08-05 |
Richard MacKay
CHM | Chairman | 91 | 2018-07-24 |
Marc Léger
BRD | Director/Board Member | 67 | 2022-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.54% | - | - | 98 | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | |
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | |
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | |
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | |
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | |
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | |
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | |
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | |
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | |
| Average | -0.11% | +0.54% | +28.13% | +55.82% | 397.23B | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.74M 19.8M 17.31M 15.97M 14.72M 1.91B 28.36M 191M 75.08M 934M 74.37M 72.74M 3.22B | 53.91M 38.48M 33.63M 31.03M 28.6M 3.71B 55.11M 371M 146M 1.81B 145M 141M 6.25B |
| Net income | -25.75M -18.38M -16.06M -14.82M -13.66M -1.77B -26.32M -177M -69.67M -867M -69.01M -67.5M -2.98B | -27.81M -19.85M -17.35M -16.01M -14.75M -1.91B -28.43M -191M -75.25M -936M -74.54M -72.91M -3.22B |
| Net Debt | 38.94M 27.79M 24.29M 22.41M 20.66M 2.68B 39.8M 268M 105M 1.31B 104M 102M 4.51B | 58.26M 41.58M 36.34M 33.53M 30.91M 4B 59.55M 401M 158M 1.96B 156M 153M 6.75B |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VPHIF Stock
- VPH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
